Picture of Bioventix logo

BVXP — Bioventix Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual income statement for Bioventix, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
UAS
UAS
UAS
UAS
UAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue11.712.813.613.113
Cost of Revenue
Gross Profit111212.711.911.9
Selling / General / Administrative Expenses
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses2.452.783.213.212.88
Operating Profit9.271010.49.910.1
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes9.2810.110.610.110.2
Provision for Income Taxes
Net Income After Taxes7.678.378.17.587.61
Net Income Before Extraordinary Items
Net Income7.678.378.17.587.61
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income7.678.378.17.587.61
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.461.581.551.451.46
Dividends per Share
Special Dividends per Share